Description: Benefits of attending the Symposium in building a knowledge framework on issues affecting longevity and older ages.

Description: This the Application Tool for Mortality Improvement Model, MIM-2021.

Description: The SOA recently launched the Mortality and Longevity Strategic Research Program with the release of a new study on the economic impact of opioid abuse. In this session, results of this study will be presented along with insights and plans for the future of the Program.

Description: Dr Horvath's research lies at the intersection of aging research, epidemiology, chronic diseases, epigenetics, genetics, and systems biology. He works on all aspects of biomarker development with a particular focus on genomic biomarkers of aging. He developed a highly accurate multi-tissue biomarker of aging known as the epigenetic clock. Dr Horvath developed systems biologic approaches such as weighted gene co-expression network analysis which lend themselves for integrating gene genomic data sets. These methods have been used for a broad spectrum of age-related diseases including neurodegenerative diseases, cancer, cardiovascular disease. Dr. Horvath received a Ph.D. in Mathematics from the University of North Carolina, Chapel Hill in 1995 and a Doctorate of Science in Biostatistics from the Harvard School of Public Health in 2000.

Description: Feature article discussing the events of the recent Living to 100 Symposium.

Description: Papers: Chronic Diseases and Longevity Risk: An Application to Type II Diabetes Insurance Products – Hsin-Chung Wang, Ph.D. - Aletheia University; Jack C. Yue, ASA, Ph.D. – National Chengchi University; Ting-Chung Chang - Chihlee University of Technology Understanding Multimorbidities - Sam Gutterman, FSA, CERA, FCA, FCAS, HONFIA, MAAA

Description: This is the user guide for the Mortality Improvement Model, MIM-2021, Data Analysis Tool

Description: A number of vendors have developed mortality scoring systems through various predictive modeling algorithms. They significantly alter the underwriting and mortality assessment landscape. You have been charged with evaluating these scoring systems. How should you go about doing it to maximize the value of your analysis and minimize the disruption to your product?At the conclusion of the session, attendees will:Learn about the types of scoring systems now available;Learn to create an action plan for evaluation; Learn how to navigate the pitfalls of evaluating something entirely new; andLearn how to integrate the score in your existing processes.

Description: Two recent SOA research projects will be discussed. The first covers analysis of the drivers of mortality that shaped trends in US mortality. The second will look at using causes of death to predict future mortality improvements